If you’re looking for MS care in Wisconsin, you’ll find specialized programs across the state including centers in Milwaukee, Green Bay, La Crosse and other regions. Use this guide to compare care options such as the Multiple Sclerosis Clinic at the Medical College of Wisconsin, Neuroscience Group, and Aurora BayCare MS Program so you can choose the center and team that best fit your needs.
6 MS treatment centers24 active clinical trialsTop centers include Medical College of Wisconsin1 provider with Medicare prescribing data
Center types in Wisconsin
Regional Neurology Group (2)
Academic MS Center (2)
Community Hospital Program (1)
Dedicated MS Practice (1)
Filter by type:
Centers with Most Active Trials in Wisconsin
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
3. Aurora BayCare MS Program2 trials
Largest Care Teams in Wisconsin
1. Gundersen Health System MS Program1 provider
MS Care by City
Active MS clinical trials in Wisconsin
See all 28 MS trials in Wisconsin →ActivePhase 4
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
Green Bay · Milwaukee
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Milwaukee · Milwaukee
ActivePhase 3
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
Novartis Pharmaceuticals
Milwaukee
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Milwaukee
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Milwaukee
ActivePhase 3
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Milwaukee
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Madison · Neenah


